Emberly Dumayas is a clinical operations professional with 20 years of progressive leadership experience as a people leader, Clinical Study Manager, Clinical Team Lead, Clinical Research Associate, and coordinator for pharmaceutical, medical device, and IVD trials/studies. She takes complex clinical trials through all phases: protocol strategy, design, budgeting, negotiation, trial management, and close-out for Phase I/II-IV, Class II/Class III, and 510(k) research.
Ms. Dumayas has built her knowledge in clinical operations through complex clinical trials at all development phases: protocol strategy, design, budgeting, negotiation, trial management, and close-out for Phase I/II-IV, Class II/Class III PMA, and 510(k) research. She took strategic leadership roles at Sio Gene Therapies as a Senior Director and as Head of Clinical Operations at Freeline Therapeutics to drive development of novel gene therapies for patients with lysosomal storage disorders such as Tay-Sachs, Sandhoff, Fabry, and Gaucher Disease. Prior to these roles she held operational roles at Sanofi, IQVIA, Grifols and Exact Sciences where she supported development of biologics, medical device, and small molecule products through clinical trials.
Ms. Dumayas received her undergraduate degree in English and Biology from Ripon College and has most recently attended courses at the University of North Carolina – Chapel Hill, Kenan-Flagler Business School to attain a Certificate in Strategic Leadership.